Cargando…
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
Asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the airway, although the drivers and site of the inflammation differ between diseases. Asthmatics with a neutrophilic airway inflammation are associated with a poor response to corticosteroids, whereas asthm...
Autores principales: | Durham, Andrew L., Caramori, Gaetano, Chung, Kian F., Adcock, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728194/ https://www.ncbi.nlm.nih.gov/pubmed/26334389 http://dx.doi.org/10.1016/j.trsl.2015.08.004 |
Ejemplares similares
-
RETRACTED ARTICLE: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide
por: Perry, Mark M., et al.
Publicado: (2018) -
Retraction Note: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide
por: Perry, Mark M., et al.
Publicado: (2021) -
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
por: Caramori, Gaetano, et al.
Publicado: (2014) -
New drugs targeting Th2 lymphocytes in asthma
por: Caramori, Gaetano, et al.
Publicado: (2008) -
Cytokine inhibition in the treatment of COPD
por: Caramori, Gaetano, et al.
Publicado: (2014)